ArticleThe American journal of pathology2002

Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis.

Jack L Arbiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.